Thursday, 19 November 2026
Business

Section 11D R&D tax incentive: the 150% deduction, who qualifies and how DSTI approval works

Section 11D R&D tax incentive: the 150% deduction, who qualifies and how DSTI approval works

The section 11D research and development tax incentive is in force as at 19 November 2026. SARS says companies carrying on approved scientific or technological R&D in South Africa until 31 December 2033 can claim a 150% deduction on their operational R&D spending. The sunset sits in the Income Tax Act itself, and nothing on the pages we read today suggests an earlier end. The catch is that the deduction depends on prior approval from the state, so the work starts with an application, not a tax return.

We checked SARS’s own page, the Department of Science, Technology and Innovation (DSTI) incentive site and the legislation DSTI hosts. Where they are silent, we say so. Our business funding pillar lists the other routes open to companies.

The deduction is 150% of qualifying spending, for companies only

Section 11D allows a company a deduction of 150% of expenditure it actually incurred “directly and solely” in carrying on the R&D in South Africa. That spending must also be incurred in the production of income and in carrying on a trade, per the Act text published in the 2023 amendment law. A company that spends R2m on qualifying work can therefore deduct R3m. It is a tax saving, not a cash grant.

DSTI says the incentive is open to companies of all sizes in all sectors. The Act wording refers to a taxpayer “that is a company”, and we found nothing on the pages we read that extends the deduction to sole proprietors or partnerships.

What counts as R&D was rewritten from 1 January 2024

The definition that DSTI’s guidelines quote reads: “systematic investigative or systematic experimental activities aimed at resolving scientific or technological uncertainty and the resolution of which is not readily deducible by a person skilled in the relevant scientific or technological field.” The old tests built around patents, registrable designs and innovative software were removed. The amendment also deleted the exclusion for internal business processes.

DSTI asks applicants to say which purpose the project serves:

  • discovering new scientific or technological knowledge;
  • creating or developing new or significantly improved products, processes or services;
  • creating or developing a multisource (generic) pharmaceutical product; or
  • conducting a clinical trial.

The two pharmaceutical routes carry extra criteria in separate regulations. Some activities stay outside the definition. The Act text DSTI hosts lists routine testing and quality control, market research and sales promotion, social science research, mineral or oil and gas exploration (except technology developed for it), financial products, and trademarks or goodwill. That list comes from a copy of section 11D that predates the 2024 changes, so check the current consolidated text before relying on it.

Some costs are shut out even on approved projects

The Act bars the deduction for immovable property, machinery, plant, implements, utensils and articles. The exception is a prototype or pilot plant built solely for the R&D and not used for production afterwards. Financing, administration and compliance costs are also excluded. SARS points to other allowances for the hardware: an accelerated 50:30:20 allowance under section 12C for machinery or plant used in R&D, and a building deduction under section 13.

Approval comes first, and DSTI runs the application

SARS says DSTI receives and processes every application, communicates with applicants and collects progress reports. Applications go through an online system that SARS says launched in October 2022. DSTI’s page sets out the steps: register or log in, complete the project form, attach documents, submit for adjudication, then report annually and notify any changes.

An adjudication committee reviews the application and recommends a decision to the Minister. SARS says it has three members from DSTI, three from SARS and one from National Treasury, assisted by external technical experts DSTI appoints. DSTI says incomplete applications are not accepted.

Have these documents ready before you start

DSTI lists what to prepare:

  • company registration and tax details, including the CIPC number and tax reference;
  • a signed authorisation letter if a representative submits for the company;
  • a detailed project description covering objectives, activities and the scientific or technological uncertainty;
  • a budget breakdown per project, covering personnel, materials, prototypes and outsourced work;
  • names, roles and qualifications of the people doing the R&D; and
  • contracts, subcontractor agreements or grant letters that affect the work.

DSTI’s guidelines add that the application must explain the uncertainty, why a skilled person could not deduce the answer, the advance sought and the closest existing product or process, called the prior art.

Timing: a six month look back, and a 2033 cut off

Before 2024, only spending from the date DSTI received the application qualified. The amendment law now allows spending “within six months prior to or on or after” that date. SARS repeats this as the condition for its own deduction.

The Act says no deduction is allowed “in respect of applications received after 31 December 2033”. SARS words it as R&D carried out until that date. We treat the Act as binding, so what matters is the date an application arrives.

Approved companies must keep reporting. The Act text on DSTI’s site requires an annual report within 12 months after each year of assessment ends, and DSTI says progress reports keep approval active. Approval can be withdrawn if material facts change.

SARS still audits, and provisional tax needs care

Approval does not end SARS’s interest. The SARS page says it checks that claimed spending falls inside what was approved and was actually incurred in the production of income. It also warns companies not to assume approval when working out provisional tax, because that carries penalties. If approval arrives after an assessment is final, the company can ask for a correction to add the expenditure.

Other tax reliefs for employers are in our guide to the section 12H learnership allowance and our look at the Employment Tax Incentive. Other state support is covered in our dtic incentives explainer.

What we could not confirm

  • How long approval takes. Neither SARS nor DSTI states a processing time on the pages we read.
  • An application fee, a minimum spend or a cap on claims. None is mentioned.
  • The current consolidated text of section 11D. The copy DSTI hosts predates the 2024 changes, so we relied on the 2023 amendment law for what changed.
  • DSTI’s eligibility and exclusions tabs. They did not load as readable text, so those points come from the Act, not DSTI’s summary.

SARS’s page was last updated on 29 October 2025, and the figures above are as at 19 November 2026. Speak to a registered tax practitioner before committing spending.